ArrowMark Colorado Holdings’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

ArrowMark Colorado Holdings’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-22,043	Closed	-$1.54M	–	350
2014 Q2	$1.54M	Hold	22,043	–	–	0.04%	193
2014 Q1	$1.61M	Buy	22,043 +43	+0.2%	+$3.21K	0.05%	182
2013 Q4	$1.51M	Buy	22,000 +7,583	+53%	+$491K	0.05%	184
2013 Q3	$916K	Buy	14,417 +7,631	+112%	+$461K	0.03%	207
2013 Q2	$328K	Buy	+6,786	New	+$334K	0.09%	98

Other funds holding CBST

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ArrowMark Colorado Holdings's CBST Position: Q3 2014 in Review

ArrowMark Colorado Holdings sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q3 2014, closing a stake of 22,043 shares — an estimated $1.54M sold.

ArrowMark Colorado Holdings first reported a position in CBST in Q2 2013 and held it in 5 quarters. The position peaked at $1.61M in Q1 2014. 254 funds tracked by Wall St. Rank hold CBST as of Q3 2014.

ArrowMark Colorado Holdings reported no remaining CUBIST PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
ArrowMark Colorado Holdings sold 22,043 CUBIST PHARMACEUTICALS INC shares in Q3 2014, an estimated $1.54M.
ArrowMark Colorado Holdings first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
ArrowMark Colorado Holdings's CUBIST PHARMACEUTICALS INC position peaked at $1.61M in Q1 2014.
254 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q3 2014.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2014, filed 14 Nov 2014.